AdaptHealth (NASDAQ:AHCO) Price Target Raised to $14.00

AdaptHealth (NASDAQ:AHCO) had its price target lifted by Truist Financial from $12.00 to $14.00 in a research report released on Wednesday,Benzinga reports. The firm currently has a buy rating on the stock.

Other research analysts also recently issued reports about the stock. Canaccord Genuity Group decreased their price target on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, November 6th. Robert W. Baird decreased their price target on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 6th. UBS Group decreased their price target on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Finally, Royal Bank of Canada decreased their price target on shares of AdaptHealth from $13.00 to $11.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 19th. Five research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth presently has an average rating of “Buy” and an average price target of $13.80.

AdaptHealth Stock Up 2.6 %

AHCO opened at $11.38 on Wednesday. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. AdaptHealth has a 1-year low of $8.35 and a 1-year high of $11.90. The company has a market capitalization of $1.53 billion, a PE ratio of -6.90, a PEG ratio of 1.08 and a beta of 1.12. The firm’s 50 day simple moving average is $9.92 and its two-hundred day simple moving average is $10.23.

Institutional Trading of AdaptHealth

Several institutional investors and hedge funds have recently modified their holdings of AHCO. Pacer Advisors Inc. bought a new stake in shares of AdaptHealth during the 4th quarter valued at $76,271,000. Principal Financial Group Inc. raised its position in shares of AdaptHealth by 204.0% during the 4th quarter. Principal Financial Group Inc. now owns 1,652,765 shares of the company’s stock valued at $15,735,000 after purchasing an additional 1,109,021 shares during the period. Segall Bryant & Hamill LLC raised its position in shares of AdaptHealth by 29.8% during the 4th quarter. Segall Bryant & Hamill LLC now owns 4,803,981 shares of the company’s stock valued at $45,734,000 after purchasing an additional 1,102,173 shares during the period. State Street Corp raised its position in shares of AdaptHealth by 19.8% during the 3rd quarter. State Street Corp now owns 4,124,284 shares of the company’s stock valued at $46,316,000 after purchasing an additional 681,816 shares during the period. Finally, FMR LLC raised its position in shares of AdaptHealth by 9.3% during the 3rd quarter. FMR LLC now owns 7,350,549 shares of the company’s stock valued at $82,547,000 after purchasing an additional 624,645 shares during the period. 82.67% of the stock is currently owned by institutional investors.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.